Status:
COMPLETED
Digital Delivery of Information About Genetic Testing for Breast Cancer
Lead Sponsor:
Institute of Cancer Research, United Kingdom
Collaborating Sponsors:
University of Sussex
University of Manchester
Conditions:
Breast Neoplasm Female
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
BRCA-DIRECT is a pragmatic, randomised, non-inferiority evaluation that aims to evaluate whether digital delivery of pre-test information for BRCA-testing in breast cancer patients is non-inferior to ...
Detailed Description
Participants will be recruited via breast clinics in two oncology centres. Patients will be provided with a study pack containing information about the study. If in clinic, the patient can complete an...
Eligibility Criteria
Inclusion
- Diagnosis of invasive breast cancer or high-grade ductal carcinoma in situ (DCIS)
- Female
- Aged 18 years or over
- Access to smartphone or email + internet
- Good comprehension of the English Language
Exclusion
- • Previous testing for BRCA1/2
Key Trial Info
Start Date :
July 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 16 2023
Estimated Enrollment :
1140 Patients enrolled
Trial Details
Trial ID
NCT04842799
Start Date
July 5 2021
End Date
January 16 2023
Last Update
May 6 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Wythenshawe Hospital
Manchester, England, United Kingdom, M23 9LT
2
Royal Marsden Hospital, Chelsea
Chelsea, London, United Kingdom, SW3 6JJ
3
Royal Marsden Hospital, Kingston
Kingston, London, United Kingdom, KT2 7QB
4
Royal Marsden Hospital, Sutton
Sutton, Surrey, United Kingdom, SM2 5PT